Sort
4,870 grants matching “glp 1”
Production of a Nanoparticle Vaccine to Aid in Smoking Cessation
$128,857Sean K Whittier · Hafion, Llc · R43 · FY2021 · DA
Experimental Mouse
$128,358Natalia A Ignatenko · University Of Arizona · P30 · FY2021 · CA
Physiological role of GLP-2 receptor in the mouse intestinal growth and function
$128,250Xinfu Guan · Baylor College Of Medicine · K01 · FY2009 · DK
Physiological role of GLP-2 receptor in the mouse intestinal growth and function
$128,250Xinfu Guan · Baylor College Of Medicine · K01 · FY2007 · DK
Physiological role of GLP-2 receptor in the mouse intestinal growth and function
$128,250Xinfu Guan · Baylor College Of Medicine · K01 · FY2006 · DK
CVD Risk and Prevention in Early Glucose Intolerance
$128,196Mary K Rhee · Emory University · K23 · FY2008 · DK
Hematopoietic Biorepository and Cellular Therapy Shared Resource
$128,093Lan Zhou · Case Western Reserve University · P30 · FY2022 · CA
Immune Monitoring and BiKE Production Core
$127,550Michael R Verneris · University Of Minnesota · P01 · FY2018 · CA
Administrative Core
$127,503Eva M Sevick-Muraca · University Of Texas Hlth Sci Ctr Houston · U54 · FY2009 · CA
Pharmacology and Pharmacometrics Core
$127,276Eric L Nuermberger · Johns Hopkins University · P30 · FY2023 · AI
Functional interrogation of host-microbial interactions in metabolic diseases
$127,125Louis Jared Cohen · Icahn School Of Medicine At Mount Sinai · R03 · FY2020 · DK
Functional interrogation of host-microbial interactions in metabolic diseases
$127,125Louis Jared Cohen · Icahn School Of Medicine At Mount Sinai · R03 · FY2021 · DK
CVD Risk and Prevention in Early Glucose Intolerance
$127,116Mary K Rhee · Emory University · K23 · FY2006 · DK
CVD Risk and Prevention in Early Glucose Intolerance
$127,116Emory University · K23 · FY2005 · DK
CVD Risk and Prevention in Early Glucose Intolerance
$127,116Mary K Rhee · Emory University · K23 · FY2009 · DK
CVD Risk and Prevention in Early Glucose Intolerance
$127,116Mary K Rhee · Emory University · K23 · FY2007 · DK
Hematopoietic Biorepository and Cellular Therapy Shared Resource
$127,044Lan Zhou · Case Western Reserve University · P30 · FY2021 · CA
Core B: Hormone & Metabolite Assay Core
$127,002Xavier F Pi-Sunyer · Columbia University Health Sciences · P30 · FY2013 · DK
Feasibility Evaluation of an Oral Typhoid Fever Vaccine
$126,861Celldex Therapeutics, Inc. · R43 · FY2003 · AI
Identification of Molecular Biomarkers in Rat Sperm and Testis Exposed to BPA
$126,643Kim Boekelheide · Brown University · U01 · FY2014 · ES
Development of a nitric oxide-releasing antiviral gel for the treatment of cervical HPV infections and prevention of downstream malignancies in women
$126,370Carri Geer · Novan, Inc. · R44 · FY2021 · AI
Development of the first topo II inhibitor for brain tumors
$126,249Raymond J Budde · Houston Pharmaceuticals, Inc. · R43 · FY2007 · CA
Etiology of Impaired Counterregulation in Glucose Homeostasis: Exploring the Roles of Glucagon, Somatostatin, Cortisol, and Epinephrine through Mathematical Modeling of Oral Glucose Tolerance Tests
$125,831Vijaya Subramanian · Johns Hopkins University · K25 · FY2022 · DK
Hematopoietic Biorepository and Cellular Therapy Shared Resource
$125,786David Wald · Case Western Reserve University · P30 · FY2020 · CA
Optimizing care for older adults in the new treatment era for type 2 diabetes and heart failure: Strengthening causal inference through novel approaches and evidence triangulation
$125,280Xiaojuan Li · Harvard Pilgrim Health Care, Inc. · K01 · FY2025 · AG